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Abstract
Aim of study: Vibrio harveyi bacteria are affecting shrimps during grow-out practices. The application of chemicals to control V. harveyi 
has resulted in antibiotic‐resistance among bacteria. An extract of the leaves of Rhizophora mucronata was tested to control the growth and 
virulences of V. harveyi.
Area of study: This study was conducted in the Crustacean Culture Division of ICAR-CIBA, Chennai city, Tamil Nadu State, India.
Material and methods: R. mucronata plants were collected from the Pitchavaram area, and the leaves contents extracted. The resultant 
extract was prepared and tested against the growth of V. harveyi and its virulence factors. The various functional compounds of R. mucronata 
were screened and volatile compounds were analyzed.
Main results: When R. mucronata extract was treated against V. harveyi (350 µg/mL) an inhibitory zone of 14 ± 0.1 mm was obser-
ved. At 300 µg/mL, the extract was found to be active in decreasing the luciferase to a maximum of 76 counts per second in 30 days and 
a similar level of bioluminescence was reduced in 15 days. During, shrimp larviculture a reduction in the cumulative percent of mortality 
15.70% (p<0.033) was observed when treated with the extract of R. mucronata.
Research highlights: When extract (200 μg/mL) of R. mucronata was tested against V. harveyi during Penaeus monodon larviculture, 
the V. harveyi counts decreased (p<0.049). Volatile compounds viz, tetramethyl-6,7,8,8a-tetrahydro-5H-naphthalene-1-one (38.63%), squa-
lene (31.19%), α-amyrin, (7.07%) and β-amyrin (8.75%) were detected. It would be desirable to use crude extracts of R. mucronata during 
shrimp culture to control V. harveyi.
Additional key words: antimicrobials; antagonism; shrimp larviculture; aquaculture
Abbreviations used: CFU (colony-forming unit); CPM (cumulative percent mortality); CPS (counts per second); DMSO (dimethyl sul-
foxide); EPS (exopolysachharide); FT-IR (Fourier-transform infrared spectroscopy); GC-MS (gas chromatography and mass spectroscopy); 
IR (reflectance infrared); MIC (minimum inhibitory concentration); PL (postlarvae). PSU (practical salinity unit); SAT (salt aggregation 
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Introduction
Vibrio is one of the virulent bacterial pathogens, 
responsible for causing large-scale mortality during the 
developmental stages of penaeid shrimps. Biolumines-
cence disease-causing Vibrio harveyi bacteria and its 
related species can affect almost all types of organisms 
(Defoirdt et al., 2007) in aquaculture. The application 
2 Sudalayandi Kannappan, Krishnamoorthy Sivakumar, Karingalakkandy P. Jithendran et al.
Spanish Journal of Agricultural Research September 2021 • Volume 19 • Issue 3 • e0506
of antimicrobials in the aquaculture system has resulted 
in bacteria developing resistance to antibiotics (Igbino-
sa et al., 2017). Edible shrimps are also perhaps a sour-
ce in spreading multiple antibiotic resistances (MAR) 
among the bacterial pathogens to the consumers (Bes-
hiru et al., 2020). Copious technologies have been de-
veloped to control bioluminescent V. harveyi causing 
disease in the aquaculture system. “Green water culture 
system” is a technique used in aquaculture, wherein the 
shrimps or fish are co-cultured with abundant microal-
gae such as Chlorella. However, the micro algae pro-
duction essential for aquaculture is yet to be quantified 
(Amir Neori, 2011). Probiotic bacteria have been used 
for monitoring bacterial infections and to reduce or-
ganic matter in shrimp grow-out practices, but more 
quantity of cells are necessary, which is cost-effecti-
ve (Defoirdt et al., 2008). There is an urgent need to 
search for other methods to control disease-causing vi-
brios, which is an imperative challenge for sustainable 
aquaculture development. It is possible that instead of 
chemicals, alternative bio-agents, extracted from ma-
rine plants/mangroves could be used to control resis-
tant marine vibrios. Rhizophora mucronata, commonly 
known as Asiatic mangrove or ‘red mangrove’ has been 
reported to have healing properties against nausea, hae-
morrhage, and angina (Manilal et al., 2015). Among the 
mangrove plants, R. mucronata, and Avicennia marina 
are known to have anti-hyperglycemic, anti-radical and 
anti-diabetic properties (Sur et al., 2015; Aljaghthmi et 
al., 2017) in humans. 
The preliminary phytochemical analysis of R. mucro-
nata revealed phenols, alkaloids, terpenoids, carbohydra-
tes, saponins, and tannins (Chitra et al., 2019). R. mucro-
nata extracts at 100 µg/mL hold more potent antioxidant 
activity than those of R. apiculata and R. annamalayana, 
as evident by the presence of phenolic N–H and OH com-
ponents found in mangroves leaves extract (Arulkumar 
et al., 2020). The fruit extract of R. stylosa was found to 
control vibriosis in larvae of the mangrove crab, Scylla 
serrata (Burhanuddin et al., 2019). R. mucronata extract 
was screened for antagonism against multi-drug resistant 
V. harveyi and V. campbellii (Baskaran & Mohan, 2012). 
The crude ethanol extract of R. mucronata could protect 
tiger shrimp from V. harveyi infection (Saptiani et al., 
2019). R. mucronata could be used as a bioindicator for 
monitoring, lead (Pb) pollution in the “ Muthupet man-
grove ecosystem ” of Tamil Nadu, India (Ganeshkumar et 
al., 2019). The methanolic fraction of R. mucronata ex-
tract offers a substantial decrease in diabetes and metabo-
lic impairment in rats (Adhikari et al., 2016). R. apiculata 
extract improved the immune system in clownfish against 
infection by V. alginolyticus (Dhayanithi et al., 2015). 
Therefore, an attempt was made, in the present study, to 
evaluate in-vitro antagonistic effect of crude extracts of 
R. mucronata on the growth and virulence factors of V. 
harveyi for protection against bioluminescence disease in 
Penaeus monodon larviculture.
Material and methods
Isolation of V. harveyi 
Vibrio harveyi bacterial strains were isolated from 
the backwaters of the Muttukadu Experimental Station 
(MES) of ICAR-CIBA at Chennai and identified by using 
various biochemical tests viz, arginine dihydrolase (-), 
lysine (+), ornithine decarboxylase (+), gelatinase (+), 
Voges-Proskauer (-), D-glucosamine (-), etc., (Abraham 
& Palaniappan, 2004) and compared with the characte-
ristics of type strain V. harveyi ATCC 25919 as a positive 
control. The isolates were re-confirmed by streaking in 
Vibrio harveyi selective agar (VHSA) medium and stored 
in VHSA slants at 4°C (Harris et al., 1996). The pathoge-
nicity of V. harveyi isolates was determined by spotting in 
3% blood agar (Hi-Media, India).
A sampling of mangrove leaves and preparation 
of crude extracts 
Leaves of R. mucronata (Fig. S1 [suppl]) were 
collected from a mangrove forest at Pichavaram in Tamil 
Nadu, India (Lat 11º27'N; Lon 79º47'E). The leaves were 
washed in a 10 mg/L solution of KMnO4 for 10 min to 
eliminate epiphytes, sand, and other extraneous matters. 
The leaves were cleaned in freshwater and shade-dried at 
room temperature for 12 hrs. Later the leaves were pulve-
rized by a sterile pestle and mortar and stored at -20ºC for 
further use. The 2.0g powder was treated with 100 mL of 
ethyl acetate and then extracted by the Soxhlet apparatus. 
The extracts were then neutralized to pH 7.0 by using 0.1 
N NaOH and filtered through Whatman filter paper No.1. 
The extracts were later dried at 42ºC in a hot air oven for 
6 hrs. For cold extraction, 1.0 g of powder was mixed with 
10 mL of ethyl acetate and thereafter placed in a shaker 
incubator at 37°C at 50 rpm for 96 hrs. The extract was 
then filtered through Whatman filter paper No.1 and rotary 
evaporated (30°C) under vacuum and stored at 4°C. The 
pH was neutralized as stated earlier. The resultant extract 
was liquefied with 5mg/mL of 30% (v/v) dimethyl sul-
foxide (DMSO) and used for testing antagonism against 
luminescent V. harveyi (Sivakumar & Kannappan, 2013).
 
Antibacterial assay 
Antibacterial activity of the extracts was carried out 
by “Agar well diffusion assay” (Das et al., 2005) against 
V. harveyi. Cells of V. harveyi (50 μL/108 CFU/mL cells 
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(18 hrs, old) were inoculated into Petri plates. The LB 
agar (35 mL) was dispensed into plates and solidified for 
1 hr at room temperature. Two wells (6.0 mm) were made 
on the LB agar plates using a sterile steel borer. The wells 
were sealed at the bottom with 10 μL of 1.0% soft agar 
and filled with 200 μL of crude leaves extract. The plates 
were then incubated at 37°C for 48 hrs and zones of inhi-
bitions on V. harveyi around the well were measured ex-
cluding the well. The antimicrobial activity of the R. mu-
cronata extract was determined by dissolving it in 30% of 
DMSO in various concentrations. DMSO was used as a 
negative control. Similarly, the extract obtained through 
“cold extraction” was also tested. Each test was perfor-
med in triplicate and values were expressed as average 
with standard deviation.
Estimation of minimum inhibitory and minimum 
bactericidal concentrations (MIC & MBC)
The minimum inhibitory concentrations (MIC) for 
the extract were evaluated as described by Islam et al. 
(2008). Dilution methods were used to determine the 
MIC. In dilution tests, V. harveyi was tested for their abi-
lity to produce visible growth against the extracts on a 
series of LB agar plates against the extracts. Several con-
centrations of extracts (5.0 to 50 μg) were tested and the 
lowest concentration which inhibited the visible growth 
of V. harveyi was observed as the MIC. The plates were 
incubated at 37°C for 24 hrs and 20 μL of V. harveyi (1.8 
OD or 2.19×107 CFU/mL) was confirmed for the MIC 
on the LB agar medium. The MBC was evaluated as the 
lowest concentration of a crude plant extract required to 
kill 99.9% of 20 μL of V. harveyi (1.8 OD or 2.19×107 
CFU/mL).
Effects of R. mucronata extract on the growth and 
virulences of V. harveyi
The leaves of extract at 300 µg/mL was added to 100 
mL of LB medium. Five hundred μL (24 hrs) of V. har-
veyi (1.8 OD) cells were inoculated into LB broth and in-
cubated under shaker incubator at 37°C for 100 rpm in 
5 days. Three mL of V. harveyi inoculum was estimated 
for their growth for 30 days at OD 600 nm. The growth 
and virulence factors such as proteolytic, lipolytic, phos-
pholipase, thermonuclease, crude bacteriocin, exopoly-
saccharide (EPS), and proteases produced were estima-
ted. Salt aggregation test (SAT) was carried out for cell 
surface hydrophobicity and cell adhesion was examined 
through bacterial adhesion to hydrocarbons test (BATH) 
(Soto-Rodriguez et al., 2012). Each test was performed 
in triplicate and values were expressed on average with 
standard deviation.
Cell lysate preparation, estimation of luciferase, 
and luminescence
The luciferase enzyme produced by V. harveyi was 
tested by the luciferase kit (LUC1, Technical Bulletin 
MB-260, and Sigma, USA) and read by a luminometer 
(Victor TM X3, Perkin Elmer, USA). V. harveyi cells 
were harvested by centrifugation at 10,000 rpm for 5 min. 
The pellet was re-suspended in 333 μL of 1X cell lysis 
buffer per mL of V. harveyi and incubated at 25°С for 10 
min. Thereafter the suspension was centrifuged at 12,000 
rpm for 1 min at 4°С. The supernatant was stored in ice. 
Luciferase substrate (lyophilized, suspended in lucifera-
se assay buffer) as cell lysate was equilibrated to 25°С 
before use. Cell lysate (20 μL) was added to 100 μL of 
the luciferase substrate and mixed well. Readings were 
recorded in 10 sec for light emission by the luminometer 
and expressed as counts per second (CPS, i.e., photons). 
The light intensity was closely constant for 20 sec. The 
LB broth medium and 1X lysis buffer were used as a ne-
gative control for luciferase assay. For the estimation of 
luminescence, the V. harveyi cells, harvested by centrifu-
gation at 10,000 rpm for 5 min, and its spent culture me-
dium, were estimated for luminescence by a luminometer 
(Kannappan et al., 2013).
Fourier transform infrared spectroscopy (FT-IR) 
analysis 
The shade-dried powder (1.0 mg) was mixed thoroughly 
with 2.5 mg of dry potassium bromide (KBr) by a pestle and 
mortar. The powder was filled in a micro-cup (2.0 mm inter-
nal diameter) to obtain the diffuse reflectance infrared (IR) 
spectrum for replicate samples. All the IR spectra were recor-
ded at 37°C in the mid-infrared range (4000-400 cm-1) using 
Fourier Transform Infrared Spectrometer (FT-IR) Bruker 
IFS 66, Shimadzu. Normally, 20 scans were signal-averaged 
for a single spectrum. Each spectrum is displayed in terms 
of absorbance as calculated from the reflectance-absorbance 
spectrum using the Hyper-IR software (D'Souza et al., 2008).
Gas chromatography and mass spectrometry 
analysis
Gas chromatography-mass spectrometry (GC-MS) 
analysis was performed by using Agilent GC-MS-5975C 
with the Triple-Axis Detector equipped with an auto sam-
pler. The GC column used was fused with a silica ca-
pillary column (length 30 m × diameter 0.25 mm × film 
thickness 0.25 mm) with 1.51 mL helium for 1 min as a 
carrier gas. The mass spectrometer was operated in the 
electron impact (EI) mode at 70 eV in the scan range of 40-
700 m/z. The split ratio was adjusted to 1:10 and injection 
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volume was 1.0 μL. The injector temperature was kept 
at 250°C, and the oven temperature was 70°C for 3 min, 
which was later increased to 250°C at 14°C/min (total run 
time 34 min). The temperature of the transfer line and the 
ion source was set to a value of 230°C and the interface 
temperature at 240°C, the full mass data being recorded 
between 50-400 Daltons and scan speed 2000. Mass start 
time was set at 5 min and end time at 35 min. Peak of the 
crude R. mucronata extract was identified by comparison 
with retention times of standards and the mass spectra ob-
tained was compared with those available in the NIST li-
braries (NIST 11-Mass Spectral Library 2011 version) with 
an acceptance criterion of a match above a critical factor of 
80% (Musharraf et al., 2012).
Effect of R. mucronata extract against V. harveyi 
during P. monodon larviculture
Plastic tubs were washed with 10 mg/mL of KMnO4 
solution (w/v) for 10 min and filled with 20 L of saline 
water at 20 practical salinity unit (PSU). Postlarvae (PL 
10) of P. monodon from a private shrimp hatchery, were 
tested by PCR to be disease-free, following Ananda Raja 
et al. (2017), for the OIE1 listed diseases, and were accli-
matized at 20 PSU for 5 days with aeration under labo-
ratory conditions. About 1000 PL, in the weight range of 
17 to 18 ± 0.2 mg were stocked per tub. The first tub was 
inoculated with V. harveyi (10 mL of 1.8 OD) alone as a 
control. The second tub was considered as treatment and 
inoculated with V. harveyi (2.0g for 10 L of the extract). 
The third tub was considered as control, where the crude 
extract was added at 200 μg/mL with PL. The fourth tub 
was a control for PL, where neither V. harveyi nor extract 
was added. Aeration was provided for each container and 
the PLs were fed twice a day at 15% of their body weight. 
All the experimental tubs were covered on the top with a 
plastic lid to avoid external contamination. The water tem-
perature, salinity, and pH were recorded once in 5 days. 
Experiments were carried out in triplicate. The mortality 
of PL was recorded daily. No water exchange was made in 
the containers for 30 days. The total heterotrophic and V. 
harveyi counts were enumerated (Traifalgar et al., 2009) 
using LB agar and V. harveyi selective agar medium under 
the spread plate method (Biswas et al., 2012).
Statistical analysis
The data were analyzed and expressed as means along 
with the standard deviation. Analysis of variance (SPSS, 
1  The former Office International des Epizooties (OIE) inter-governmental organization coordinating, supporting and promoting animal disease control, is now called World Or-
ganisation for Animal Health
ver. 16.0) was carried out to find the significance (p<0.05) 
difference, if any. The cumulative percent mortality 
(CPM) was calculated as a Cumulative frequency/total 
number of observations (n) ×100.
Results 
Antagonism of leaves extracts of R. mucronata
The results of the antimicrobial assay of crude R. mu-
cronata extracts at 200, 250, 300, 350 and 400 µg/mL con-
centration showed 8.0 ± 0.2, 10.0 ± 0.1, 12.0 ± 0.1, 14.0 ± 
0.1 and 16.0 ± 0.20 mm zones of inhibitions, respectively 
(excluding the well 8.0 ± 0.2 mm). As a positive control, 
10 µL of oxytetracycline (250 mg/25 mL) showed a zone 
of inhibition of 23.0 ± 0.9 mm, whereas the DMSO as ne-
gative control showed no inhibition. The crude extract un-
der cold extraction at concentrations of 200, 250, 300, 350 
and 400 µg/mL showed 5.0 ± 0.1, 6.0 ± 0.1, 7.0 ± 0.2, 8.0 
± 0.1, 9.0 ± 0.2 mm zone of inhibitions, respectively. The 
MIC of crude extract at 300 µg/mL concentration showed 
6.0 ± 0.10 mm against V. harveyi and a MBC value of 12.0 
± 0.20 mm (Fig. S2 [suppl])).
Effects of R. mucronata extract on growth and 
virulences of V. harveyi
The crude extract showed the maximum active an-
tagonistic efficiency to control the growth of V. harveyi 
(OD) from the 5th day onwards. The highest OD diffe-
rence was observed on the 20th day (0.37) compared to 
the control and the lowest on the 10th day (p<0.05). The 
bioluminescence production was decreased from 1100 to 
2200 CPS against the R. mucronata extract for 30 days 
as compared to control (Table 1). The maximum control 
on bioluminescence was detected on the 15th day (2230 
CPS) and the minimum was on the 25th day (1090 CPS) 
(p<0.05). The production of intracellular luciferase by V. 
harveyi was decreased with the addition of extract from 
20 to a maximum of 76 CPS in 30 days (Fig. 1). Table 
1 shows that the maximum decrease in bacteriocin pro-
duction (OD) by the extract was observed between the 
5th and 15th days (0.39 and 0.27 respectively, p<0.05). 
The maximum decrease in protease was 0.15 OD against 
the extract on the 20th day. Treatment with the extract 
showed a weak level (+) of phospholipase, produced 
by V. harveyi as compared to very high phospholipase 
(++++) in the control for all the 30 days. In SAT, V. har-
veyi revealed strong hydrophobic activity from the 5th 
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to 30th day in the control whereas, the treatment showed 
moderate to weak hydrophobic activities.
FT-IR analysis of R. mucronata extract 
The FT-IR spectrum of dried leaves powder reveals 
various functional groups of compounds that were com-
pared with the FTIR standard library data. The FT-IR 
spectrum showed the presence of significant functional 
groups such as aromatics, alkanes, alcohol, carboxylic 
acids, esters, ethers, aliphatic amines, and alkyl halides 
(Table 2).
GC-MS analysis of the R. mucronata extract
To document preliminary data on bioactive com-
ponents, ethyl acetate extract was subjected to GC-
MS analysis. The crude extract was found to have a 
mixture of secondary and volatile compounds. Fat-
ty acid methyl esters were investigated quantitatively 
by GC-MS in multiple reactions monitoring the mode 
and thus allowing a better signal resolution without a 
preliminary fractionation of the extract. A total of 21 
peaks were observed with retention times as presented 




5 10 15 20 25 30
Luciferase (CPS)
   Treatment 143 120 150 172 110 115
   Control 182 196 188 192 140 180
Salt aggregation test (SAT)[a] (moles L-1) 
   Treatment 1.60 1.40 1.75 1.95 2.30 2.00
   Control 0.50 0.65 0.70 0.80 0.65 0.60
Bacteriocin OD at 660 nm [b]
   Treatment 2.323±0.01 2.401±0.02 2.251±0.03 2.362±0.05 2.003±0.05 1.642±0.09
   Control 2.719±0.08 2.604±0.02 2.524±0.04 2.409±0.01 2.146±0.02 1.835±0.06
Protease OD at 440 nm
   Treatment 0.080±0.01 0.046±0.06 0.016±0.03 0.051±0.02 0.039±0.01 0.017±0.01
   Control 0.143±0.08 0.164±0.07 0.172±0.02 0.198±0.01 0.174±0.01 0.134±0.01
Growth OD at 600 nm
   Treatment 0.683±0.02 0.649±0.01 0.688±0.03 0.363±0.01 0.742±0.02 0.617±0.01
   Control 0.860±0.01 0.700±0.03 0.870±0.01 0.735±0.01 0.833±0.01 0.761±0.01
Luminescence produced (CPS)
   Treatment 82115 82200 84550 83150 85410 81120
   Control 83306 83500 86780 84410 86500 82510
Phospholipase activity [c]
   Treatment + + + + + +
   Control +++ +++ ++++ ++++ ++++ ++++
CPS: counts per second. [a] SAT test: 0.0 to1.0 M = strongly hydrophobic; 1.0 to 2.0 M = moderately hydrophobic; 2.0 to 4.0 M = weakly 
hydrophobic; >4.0 M = not hydrophobic. [b] BATH test: >50% partitioning = strongly hydrophobic; 20 to 50% partitioning = moderately 
hydrophobic; < 20% partitioning = not hydrophobic. [c] Activity of V. harveyi: + = weak, ++ = moderate, +++ = high, ++++ = very high. 














Figure 1. Effect of R.mucronata extract against luciferase pro-
duced by V. harveyi. Significant differences (p<0.033) found in 
the reduction of luciferase produced in treatment against the 
control). CPS: counts per second.
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Frequency (cm-1) Bond Functional group
3446.4 O-H stretch, H bonded Alcohols, phenols
2922.8 O-H stretch Carboxylic acid
C-H stretch Alkanes
1735.8 C=O stretch Carbonyls (general), carboxylic acid, ester, saturated aliphatic, aldehyde
1699.9 C=O stretch α,β–unsaturated aldehydes, ketones, carbonyls (general), carboxylic acid
1651.3 –C=C– stretch Alkenes
1638.8 N–H bend Primary amine
1541.7 N–O asymmetric stretch Nitro compounds
1523.3 N–O asymmetric stretch Nitro compounds
1440.4 C–C stretch (in–ring) Aromatics
1317.3 N–O symmetric stretch Nitro compounds
C–N stretch Aromatic amines
C–O stretch Alcohols, carboxylic acids, esters, ethers
1255.9 C–H wag (–CH2 X) Alkyl halides
C–O stretch Alcohols, carboxylic acids, esters, ethers
C–N stretch Aliphatic amines
1104.4 C–O stretch Alcohols, carboxylic acids, esters, ethers
C–N stretch Aliphatic amines
1067.1 C–O stretch Alcohols, carboxylic acids, esters, ethers
C–N stretch Aliphatic amines
583.84 C–Cl stretch Alkyl halides
C–Br stretch
527.04 C–Br stretch Alkyl halides
Table 2. Wave number (cm-1) of dominant peaks obtained from the FT-IR absorption spectra of leaves extract of R. mucronata.
 
Figure 2. GC-MS profile of R. mucronata extracts showing various peaks as a 
mixture of volatile compounds
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(38.63% peak area), followed by squalene (31.19% peak 
area), α-amyrin, (7.07%) and β-amyrin (8.75%). These 
bioactive compounds could be involved in the antago-
nistic activity (Table 3) against V. harveyi along with 
other compounds. Chemical constituents were identified 
using spectrum database NIST 11 software installed in 
GC-MS. 
Effects of the extract of R. mucronata against V. 
harveyi during P. monodon larviculture 
During the larviculture of P. monodon, the mortality 
varied from 0 to 50.81% till the 30th day after treatment 
with the extract. The CPM increased in the control from 
4% on the 5th day to 66.5% on the 30th day respectively. 







1 4.830 phenol 0.19 C6H6O 94.042
2 8.547 1-dodecene 0.37 C12H24 168.188
3 11.467 1-tetradecene 0.54 C14H28 196.219
4 12.933 phenol, 2,4-bis(1,1-dimethylethyl) 0.54 C14H22O 206.167
5 13.180 5,9,13-pentadecatrien-2-one, 6,10,14-trime-thyl-, (E,E)- 0.20 C18H30O 262.23
6 13.994 cetene 0.63 C16H32 224.25
7 15.838 tetradecanoic acid 0.21 C14H28O2 228.209
8 16.245 1-nonadecene 0.68 C19H38 266.297
9 16.695 3-eicosyne 0.89 C20H38 278.297
10 16.956 phthalic acid, butyl tetradecyl ester 0.25 C26H42O4 418.308
11 17.145 bicyclo[4.1.0]heptane, 3-methyl- 0.24 C8H14 110.11
12 17.929 n-hexadecanoic acid 0.89 C16H32O2 256.24
13 18.292 5-eicosene, (E)- 0.72 C20H40 280.313
14 18.990 hexadeca-2,6,10,14-tetraen-1-ol, 3,7,11,16-te-tramethyl- 0.25 C20H34O 290.261
15 19.599 7,10,13-hexadecatrienoic acid, methyl ester 0.27 C17H28O2 264.209
16 20.137 n-nonadecanol-1 0.23 C19H40O 284.308
17 22.780 1,5,9-decatriene, 2,3,5,8-tetramethyl- 0.28 C14H24 192.188
18 25.046 squalene 31.19 C30H50 410.391
19 25.205 (e,e,e)-3,7,11,15-tetramethyl hexade-ca-1,3,6,10,14-pentaene 0.34 C20H32 272.25
20 25.641 eicosane 0.58 C20H42 282.329
21 25.772 2,6,10-dodecatrien-1-ol, 3,7,11-trimethyl-, (Z,E)- 1.24 C15H26O 282.329
22 25.859 2,2,4-trimethyl-3-(3,8,12,16-tetramethyl-hep-tadeca-3,7,11,15-tetraenyl)-cyclohexanol 1.36 C30H52O 428.402
23 25.946 2-methyl-3-(3-methyl-but-2-enyl)-2-(4-me-thyl-pent-3-enyl)-oxetane 1.82 C15H26O 222.198
24 26.295 2,6,10,14,18-pentamethyl-2,6,10,14,18-eico-sapentaene 0.61 C25H42 342.329
25 26.367 1,6,10,14,18,22-tetracosahexaen-3-ol, 2, 6, 10, 15, 19,23-hexamethyl-, (all-E)- 0.30 C30H50O 426.386
26 27.079 octacosane 0.35 C28H58 394.454
27 27.340 vitamin E 0.38 C29H50O2 430.381
28 29.562 2,5,5,8a-tetramethyl-6,7,8,8a-tetrahy-dro-5h-naphthalen-1-one 38.63 C14H20O 204.151
29 29.766 beta-amyrin 8.75 C30H50O 426.386
30 29.853 alpha-amyrin 7.07 C30H50O 426.386
Table 3.  GC-MS profile of R. mucronata leaves extract.
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The difference in the overall decrease of CPM among the 
treatments was 12 to 16% as compared to control from 
20th to 30th days. On the 30th day, a maximum reduction of 
15.70% was found in the treatment, compared to control. 
The growth of postlarvae uniformly increased from 4-7 
mg on the 10th day. The growth of V. harveyi when treating 
with the extract treatment was from 5.2×104 to 3.2×103 
CFU/mL on the 30th day as compared to control (9×105 
to 1.0×103 CFU/mL). In the treatment, the total heterotro-
phic bacterial (THB) count decreased from 4.3×104 CFU/
mL to 1.2×103 CFU/mL, compared to control (6.9×104 to 
7.2×103 CFU/mL) (Table 4). Significant differences were 
found in CPM (p<0.033) and V. harveyi counts (p<0.049) 
between the leaves extract of R. mucronata treated with 
V. harveyi and control. 
Discussion
Mangroves are a potential source of various com-
pounds with higher biological activity than toxicity (Mani-
lal et al., 2010). The compounds are used as antimicrobial 
agents and in pharmaceutical preparations. In this study, 
crude R. mucronata extracts showed inhibition on V. har-
veyi, but the extract obtained through the Soxhlet method 
gave a better inhibition than cold extraction. The crude 
extract obtained from the bark and collar of the Asiatic 
mangrove showed inhibition on V. harveyi (7.0 mm) and 
various other fish pathogens (Kesavaraju & Sreeramulu, 
2017). The extract also showed anti-fungal activities on 
Acremonium sp and Aspergillus niger at a concentration 
of 75 µg/mL (Arunprabu et al., 2016). Kannappan et al. 
(2018) reported the inhibition on bioluminescence disea-
se-causing V. harveyi (12 mm at 350 µg/mL) by the crude 
extract of R. apiculata. The mechanism of inhibition on V. 
harveyi was due to the phytochemicals such as alcohols, 
phenols, alkanes, carbonyls, unsaturated aldehydes, nitro 
compounds, aromatics, esters, ethers, alkyl halides & ali-
phatic amines present in the crude extracts alone and not 
by DMSO or pH of the extract which was neutralized du-
ring the experiment. Ernawati & Hasmila (2016) reported 
that the secondary metabolites present in the leaf extract 
of R. mucronata were flavonoids and steroid compounds. 
The presence of phenol and flavonoid contents of the R. 
mucronata has been proved for its antioxidant properties 
(Kaur et al., 2019). Treatment of the crude extract showed 
a weak level of phospholipase against V. harveyi. It also 
revealed strong hydrophobic activity on the 30th day in 
the control experiment indicating, therefore, that the ex-
tract definitely can be used to control V. harveyi. The R. 
apiculata extract treatment, showed a weak level of phos-
pholipase produced from V. harveyi and showed moderate 
Variables
Days
0 5 10 15 20 25 30
CPM
   Control (PL with V. harveyi) 0 4.0 ± 0.2 11.1 ± 0.5 21.0 ± 0.9 46.1 ± 1.6 58.8 ± 2.0 66.5 ± 2.2
   Treatment (PL with extract and V. harveyi) 0 3.0 ± 0.2 12.0 ± 0.3 18.6 ± 1.4 34.6 ±1.2 46.9 ±1.7 50.8 ±2.1
   Control (PL with extract) 0 2.9 ± 0.1 5.8 ±0.4 10.9 ± 0.2 11.0 ± 0.2 12.51±0.4 16.9 ±2.0
   Control (PL alone) 0 4.0 ±0.1 8.1 ±0.2 15.5 ±0.4 27.7 ±0.3 30.3 ±1.5 35.1 ±1.0
Treatment tubs (CFU/mL)
   Total plate count 4.3×104 3.8×104 5.9×103 4.5×103 2.2×103 1.0×103 1.2×103
   V. harveyi count 5.2×104 6.2×103 5.7×103 3.0×103 1.7×103 2.0×103 3.2×103
   Total plate count 6.9×104 2.0×104 8.0×103 4.0×103 1.5×103 1.3×103 7.2×103
   V. harveyi count 9.0×105 1.6×104 8.9×103 5.7×103 1.2×103 1.1×103 1.0×103
Average body weight of PL (mg)
   Treatment tubs 18.5 ± 2 61 ± 2 113 ± 2 165 ± 2 215 ± 2 262 ± 2 268 ± 3
   Control tubs 18.0 ±3 57.6 ± 2 120 ± 2 162.8 ± 3 212 ± 3 259.2 ± 6 291.9 ±21
Water quality variables (Treatment and Control)
   Temperature (°C) 28 ± 1.0 28 ± 1.0 28 ± 1.0 29 ± 1.0 28 ± 1.0 29 ± 1.0 28 ± 1.0
   Salinity (PSU) 18 ± 0.5 18 ± 0.5 18 ± 0.5 18 ± 0.5 19 ± 0.5 19 ± 0.5 19 ± 0.5
   pH in control tubs 8.2 ± 0.2 8.3 ± 0.2 8.1 ± 0.2 8.3 ± 0.2 8.2 ± 0.2 8.1 ± 0.2 8.3 ± 0.2
   pH in treatment tubs 8.3 ± 0.2 8.3 ± 0.2 8.2 ± 0.2 8.3 ± 0.2 8.2 ± 0.2 8.3 ± 0.2 8.3 ± 0.2
Values are the average of three determinations with a standard deviation (SD). PL: postlarvae. PSU: practical salinity unit (1 PSU = 
1 g/kg). 
Table 4. Effect of extracts of R. mucronata against cumulative percent mortality (CPM) decrease in P. monodon postlarvae caused 
by V. harveyi.
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to weak hydrophobic activities (Kannappan et al., 2018). 
The methanol extract of R. apiculata and R. mucronata 
(1.0 mg/mL) showed a reduction of the virulence factors 
like protease, pyocyanin pigments, and biofilm produ-
ced by Pseudomonas aeruginosa (Musthafa et al., 2013). 
Quebrachitol, a bioactive compound extracted from the 
R. mucronata inhibited biofilm and virulence production 
in Staphylococcus epidermidis by impairment of initial 
attachment and intercellular adhesion (Karuppiah & Thi-
runanasambandham, 2020). The extract of R. mucronata 
showed a maximum decrease in bioluminescence pro-
duction on the 15th day and the minimum decrease was 
on the 25th day. The production of intracellular luciferase 
also decreased on the 30th day. The methanol extracts of R. 
apiculata and R. mucronata showed significant inhibition 
against quorum-sensing dependent virulence factors such 
as protease, elastase, and production of pyocyanin and bio-
film in P. aeruginosa PAO1 (Annapoorani et al., 2013). 
We found numerous significant biochemical com-
pounds in R. mucronata (Table 3). In our study, the main 
phytoconstituents detected from R. mucronata were tetra-
methyl-6,7,8,8a-tetrahydro-5H-naphthalene-1-one, squale-
ne, α-amyrin, and β-amyrin. In particular, the tetramethyl 
compounds have been reported to exhibit anticancer and 
antioxidant activity (Mohammed et al., 2016). Also, bioac-
tive components such as alkaloid, tannin, saponin and fla-
vonoid extracted from the ripe fruit of R. mucronata were 
found to lower the blood glucose level in rats (Hardoko et 
al., 2015). The squalene detected from the R. mucronata 
extract is an organic compound normally obtained from 
shark liver oil for commercial purposes. Adhikari et al. 
(2018) reported that R. mucronata leaves contained magne-
sium and squalene contents. R. mucronata-based squalene 
also may be used in the formulation of a wide variety of 
cosmetic products. Palaniyandi et al. (2018) found in-vitro 
anti gastric cancer activity of squalene, isolated from R. mu-
cronata leaves against AGS cell line.
During the P. monodon larviculture, the mortality was 
reduced significantly when the extract was used to a con-
siderable level. The CPM caused by V. harveyi decreased 
in postlarvae, (12-16% from 20-30th days by treating with 
the extract). Saptiani et al. (2019) reported that the etha-
nol extract (1500 ppm) of R. mucronata leaves inhibited 
V. harveyi and protected the tiger shrimp from infection 
with an improved survival rate and this treatment was akin 
to one using antibiotics. Dietary administration of crude 
extract of R. mucronata was found to enhance the growth 
response and innate immunity of clownfish (Dhayanithi 
et al., 2020). Fermented mangrove propagules of R. mu-
cronata have been used in fish feed, causing no negative 
effects on the growth of Nile tilapia fish fry (Andriani et 
al., 2018). The crude extract of R. apiculata at 200 μg/
mL, when tested against V. harveyi during larviculture of 
P. monodon, reduced mortality by 10.6% (Kannappan et 
al., 2018). Nurhidayah & Atmomarsono (2020) reported 
on the potential of R. mucronata against disease-causing 
V. harveyi in tiger shrimp, with a MIC ranging between 
1.0 and 10,000 mg/L. Similarly, the use of bark extract of 
R. mucronata extract (64.0 ppm) also resulted in curing V. 
harveyi infection with an enhanced survival rate (76.66%) 
in Nile Tilapia fish (Mulyani et al., 2020). Also, the fruit 
extract of R. stylosa showed anti-vibrio activities as the 
cause of Vibriosis in mangrove crab larvae (Scylla serra-
ta) (Burhanuddin et al., 2019).
The growth of postlarvae increased when treated with 
the R. mucronata extract treatment coupled with the decrea-
sed total heterotrophic bacterial load. Even, R. apiculata 
plantation improved the water quality, growth, and health 
of mud crab (Scylla paramamosain) during the grow-out 
system, and promoted gut microbiota (Dai et al., 2020). R. 
mucronata has been used in traditional medicine as an an-
tiseptic, antibacterial, and anti-inflammatory agent (Sugan-
thy & Devi, 2016). The values observed from the bio-assay 
of R. mucronata extract against the V. harveyi during P. mo-
nodon larviculture (p<0.05). Our study revealed significant 
differences between the extract-treated V. harveyi infection 
and control. Also exposed the anti-vibrio and anti-virulence 
potential of R. mucronata extract against bioluminescent 
V. harveyi and forms the baseline information for further 
research on other mangrove species.
In summary, our results reveal that the extracts of R. 
mucronata hold potent phytoconstituents which inhibit the 
growth and modulate the virulence factors produced by V. 
harveyi. Further, the extract was found to control the mor-
tality caused by V. harveyi in the P. monodon larviculture 
and could be used as an alternative agent against aquacul-
ture bacterial pathogens. Moreover, the purification of crude 
extracts of R. mucronata will provide huge opportunities on 
the detection of many bioactive compounds that could be 
utilized for making eco-friendly therapeutics. The chemical 
constituents inherent in R. mucronata were also presented. 
With the succeeding research on this plant, it is apparent that 
there are still unexplored new impending compounds ob-
tainable from this plant. The cost of production of extract 
would be lower as compared to molecular grade chemicals 
used in animal experiments. The application of such bio-pro-
ducts would reduce the undesirable effects caused by the 
use of chemical preservatives in aquaculture with reduced 
production cost and also be eco-friendly. Furthermore, we 
intend to assess the effect of R. mucronata extract on the 
equilibrium between the growth and survival among the P. 
monodon postlarvae against V. harveyi in follow-up studies.
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